References
- CraigJPNicholsKKAkpekEKTFOS DEWS II Definition and Classification ReportOcul Surf201715327628328736335
- [No authors listed]The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf200752759217508116
- HaganSMartinEEnríquez-de-SalamancaATear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicineEpma J201671527413414
- ChenWCaoHLinJOlsenNZhengSGBiomarkers for primary Sjögren’s syndromeGenomics Proteomics Bioinformatics201513421922326362815
- MatheisNGrusFHBreitenfeldMProteomics differentiate between thyroid-associated orbitopathy and dry eye syndromeInvest Ophthalmol Vis Sci20155642649265625829418
- HaganSTomlinsonATear fluid biomarker profiling: a review of multiplex bead analysisOcul Surf201311421923524112226
- Enríquez-de-SalamancaACastellanosESternMETear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseaseMol Vis20101686287320508732
- SamburskyRPresence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eyeClin Ophthalmol2016102337234327920494
- JonesLDownieLEKorbDTFOS DEWS II Management and Therapy ReportOcul Surf201715357562828736343
- SchmidlDSchmettererLWitkowskaKJTear film thickness after treatment with artificial tears in patients with moderate dry eye diseaseCornea201534442142625651494
- Pinto-BonillaJCdel Olmo-JimenoALlovet-OsunaFHernández-GalileaEA randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndromeTher Clin Risk Manag2015111159560325926736
- SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol2000118561562110815152
- Monchy deIGendronGMiceliCPogorzalekNMarietteXLabetoulleMCombination of the Schirmer I and phenol red thread tests as a rescue strategy for diagnosis of ocular dryness associated with Sjogren’s syndromeInvest Ophthalmol Vis Sci2011525167.e7321546532
- MengherLSBronAJTongeSRGilbertDJA non-invasive instrument for clinical assessment of the pre-corneal tear film stabilityCurr Eye Res198541173979089
- LempMAReport of the National Eye Institute/Industry workshop on Clinical Trials in Dry EyesClao J1995214e32
- van BijsterveldOPDiagnostic tests in the Sicca syndromeArch Ophthalmol196982110e414e44183019
- MrugaczMKasackaIBakunowicz-LazarczykAKaczmarskiMKulakWImpression cytology of the conjunctival epithelial cells in patients with cystic fibrosisEye20082291137114017525773
- KaurSMomiNChakrabortySAltered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosisPLoS One201493e9274224671186
- CorralesRMNarayananSFernándezIOcular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndromeInvest Ophthalmol Vis Sci201152118363836921931132
- PflugfelderSCJonesDJiZAfonsoAMonroyDAltered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis siccaCurr Eye Res19991920121110487957
- LamHBleidenLde PaivaCSFarleyWSternMEPflugfelderSCTear cytokine profiles in dysfunctional tear syndromeAm J Ophthalmol2009147219820518992869
- BoehmNRiechardtAIWiegandMPfeifferNGrusFHProinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarraysInvest Ophthalmol Vis Sci201152107725773021775656
- LamHBleidenLde PaivaCSFarleyWSternMEPflugfelderSCTear cytokine profiles in dysfunctional tear syndromeAm J Ophthalmol2009147219820518992869
- PflugfelderSCAntiinflammatory therapy for dry eyeAm J Ophthalmol2004137233734214962426
- VogelRCrockettRSOdenNLaliberteTWMolinaLSodium Hyaluronate Ophthalmic Solution Study Group. Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)Am J Ophthalmol2010149459460120346777
- ChenWZhangXLiuMTrehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosisExp Eye Res200989331131819345212
- CejkováJArdanTCejkaCLuyckxJFavorable effects of trehalose on the development of UVB-mediated antioxidant/pro-oxidant imbalance in the corneal epithelium, proinflammatory cytokine and matrix metalloproteinase induction, and heat shock protein 70 expressionGraefes Arch Clin Exp Ophthalmol201124981185119421494875
- LiJRoubeixCWangYTherapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental systemMol Vis20121831732922355243
- LiZChoiJ-HOhH-JParkS-HLeeJ-BYoonKCEffects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced Murine dry eyeCurr Eye Res201439987187824559509
- DaullPFerailleLElenaPPGarrigueJSComparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scrapingJ Ocul Pharmacol Ther201632210911826751507
- TsengC-LHungY-JChenZ-YFangH-WChenK-HSynergistic effect of artificial tears containing epigallocatechin gallate and hyaluronic acid for the treatment of rabbits with dry eye syndromePLoS One2016116e015798227336157
- MartinEOliverKMPearceEITomlinsonASimmonsPHaganSEffect of tear supplements on signs, symptoms and inflammatory markers in dry eyeCytokine2018105105374429452970